Please Wait.....
Report
US and Europe Gene Editing Market Forecast to 2030 - Country Analysis by Technology [CRISPR, TALEN, Antisense, Zinc Finger Nucleases (ZFNs), and Others], Product and Service (Reagents and Consumables, Instruments, and Others), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, and Others)
Market Report I 2023-08-10 I 146 Pages I The Insight Partners
The US & EU gene editing market is projected to reach US$ 15,052.92 million by 2030 from US$ 3,955.09 million in 2022; it is expected to grow at a CAGR of 18.2% from 2022 to 2030.
The factors such as rise in the prevalence of cancer and other genetic disorders and continuous technological advancements in gene editing tools are expected to drive the US & EU gene editing market growth. Moreover, growing innovations and rising investments in biotechnology is also expected to foster the US & EU gene editing market growth during the forecast period. However, the high cost of production of gene editing methods may hinder the US & EU gene editing market growth.
Strategic Initiatives by Market Players to Develop New Products to Boost the US & EU Gene Editing Market in Future
Technological developments in healthcare IT allow the use of artificial intelligence (AI) for manufacturing CRISPR Systems. Developers working in the healthcare IT domain are engaged in analyzing the processes to control and monitor all the stages of product development. The focus is to develop technologies from discovering biomarkers to clinical trials and patient monitoring. A few companies have initiated implementing their expertise to use AI for digital manufacturing. In February 2023, Sherlock Biosciences, which develops CRISPR, synthetic biology, and artificial intelligence (AI) technologies, acquired Sense Biodetection, an Oxford, UK-based developer of a rapid molecular testing platform. This acquisition accelerates Sherlock's ability to put the most advanced CRISPR-based diagnostics conveniently in the hands of global consumers.
In January 2020, ERS Genomics and New England Biolab collaborated to develop and commercialize CRISPR gene modification tools and reagents. New England Biolab offers the largest selection of recombinant and native enzymes for genomic research. The company continues expanding its product offerings into new research areas, including genome editing. As a provider of CRISPR/Cas9 reagents and tools, NEB's license from ERS Genomics expands the company's rights to use and sell these technologies.
Thus, such initiatives are expected to foster genome editing and enhance the US & EU gene editing market growth in the coming years.
The US & EU gene editing market is segmented on the basis of technology, product and services, application, and end user. Based on the technology is segmented into CRISPR, TALEN, antisense, Zinc Finger Nucleases (ZFNs), and others. In 2022, the CRISPR segment held the largest share of the US & EU gene editing market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the products and services is segmented into reagents and consumables, instruments, and others. In 2022, the reagents and consumables segment held the largest share of the US & EU gene editing market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the application is segmented into cell line engineering, genetic engineering, diagnostic application, drug discovery, and others. In 2022, the cell line engineering segment held the largest share of the market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the end user is segmented into pharmaceutical & biotechnology companies, academic and research institutes, contract research organization (CROs), others. In 2022, the pharmaceutical & biotechnology companies segment held the largest share of the US & EU gene editing market. However, the academic and research institutes segment is expected to grow at the fastest rate during the coming years.
The World Health Organization (WHO), Centre For Research in Agricultural Genomics (CRAG), Centers for Disease Control and Prevention (CDC), Department For Environment, Food, And Rural Affairs (DEFRA), Food And Agricultural Organization (FAO), US Food and Drug Administration (FDA), Italian Society of Agricultural Genetics (SIGA) are among some of the primary and secondary sources referred to while preparing the report on the US & EU gene editing market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 US and Europe Gene Editing Market- By Technology
1.3.2 US and Europe Gene Editing Market- By Products and Services
1.3.3 US and Europe Gene Editing Market- By Application
1.3.4 US and Europe Gene Editing Market- By End User
1.3.5 Gene Editing Market- By Geography
2. Executive Summary
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. US and Europe Gene Editing Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 US - PEST Analysis
4.2.2 Europe - PEST Analysis
4.3 Expert Opinions
5. Gene Editing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Cancer and Other Genetic Disorders
5.1.2 Continuous Technological Advancements in Gene Editing Tools
5.2 Market Restraints
5.2.1 High Cost of Production of Gene Editing Methods
5.3 Market Opportunities
5.3.1 Growing Biotechnology Industry in US and Europe
5.4 Future Trends
5.4.1 Strategic Initiatives by Market Players to Develop New Products
5.5 Impact Analysis
6. Gene Editing Market - US and Europe Analysis
6.1 US and Europe Gene Editing Market Revenue Forecast and Analysis
6.2 Market Positioning of Key Players
7. US and Europe Gene Editing Market Analysis - By Technology
7.1 Overview
7.1.1 US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
7.2 CRISPR
7.2.1 Overview
7.2.2 US and Europe CRISPR Market Revenue and Forecasts to 2030 (US$ Million)
7.3 TALEN
7.3.1 Overview
7.3.2 US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
7.4 Antisense
7.4.1 Overview
7.4.2 US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
7.5 Zinc Finger Nucleases (ZFNs)
7.5.1 Overview
7.5.2 US and Europe Zinc Finger Nucleases (ZFNs)Market Revenue and Forecasts to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
8. US and Europe Gene Editing Market Analysis - By Products and Services
8.1 Overview
8.1.1 US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
8.2 Reagents and Consumables
8.2.1 Overview
8.2.2 US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
8.3 Instruments
8.3.1 Overview
8.3.2 US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
9. US and Europe Gene Editing Market Analysis - By Application
9.1 Overview
9.1.1 US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
9.2 Cell Line Engineering
9.2.1 Overview
9.2.2 US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
9.3 Genetic Engineering
9.3.1 Overview
9.3.2 US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
9.4 Diagnostic Application
9.4.1 Overview
9.4.2 US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
9.5 Drug Discovery
9.5.1 Overview
9.5.2 US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
10. US and Europe Gene Editing Market Analysis - By End User
10.1 Overview
10.1.1 US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Overview
10.2.2 US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
10.3 Academic and Research Institutes
10.3.1 Overview
10.3.2 US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
10.4 Contract Research Organization (CROs)
10.4.1 Overview
10.4.2 US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
11. US and Europe Gene Editing Market Analysis
11.1 US Gene Editing Market Revenue Forecast and Analysis
11.1.1 Overview
11.1.2 US: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
11.1.3 US: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.1.4 US: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.1.5 US: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.1.6 US: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2 Europe Gene Editing Market Revenue Forecast and Analysis
11.2.1 Overview
11.2.2 Europe: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
11.2.3 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.4 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.5 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.6 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.7 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Country (%)
11.2.8 Germany: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
11.2.8.1 Germany: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
11.2.8.2 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.8.3 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.8.4 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.8.5 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.9 UK: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
11.2.9.1 UK: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
11.2.9.2 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.9.3 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.9.4 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.9.5 UK: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.10 France: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
11.2.10.1 France: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
11.2.10.2 France: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.10.3 France: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.10.4 France: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.10.5 France: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.11 Italy: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
11.2.11.1 Italy: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
11.2.11.2 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.11.3 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.11.4 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.11.5 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.12 Spain: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
11.2.12.1 Spain: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
11.2.12.2 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.12.3 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.12.4 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.12.5 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
11.2.13 Rest of Europe: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
11.2.13.1 Rest of Europe: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
11.2.13.2 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
11.2.13.3 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
11.2.13.4 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
11.2.13.5 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in US and Europe Gene Editing Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Merck KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Lonza Group AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Horizon Discovery Group plc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Integrated DNA Technologies, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 GenScript Biotech Corporation
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 New England Biolabs
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eurofins Scientific SE
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CRISPR Therapeutics
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Editas Medicine Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 ElevateBio LLC
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 Glossary of Terms
LIST OF TABLES
Table 1. US: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
Table 2. US: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
Table 3. US: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
Table 4. US: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
Table 5. Europe: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
Table 6. Europe: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
Table 7. Europe: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
Table 8. Europe: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
Table 9. Germany: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
Table 10. Germany: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
Table 11. Germany: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
Table 12. Germany: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
Table 13. UK: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
Table 14. UK: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
Table 15. UK: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
Table 16. UK: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
Table 17. France: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
Table 18. France: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
Table 19. France: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
Table 20. France: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
Table 21. Italy: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
Table 22. Italy: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
Table 23. Italy: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
Table 24. Italy: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
Table 25. Spain: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
Table 26. Spain: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
Table 27. Spain: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
Table 28. Spain: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
Table 29. Rest of Europe: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
Table 30. Rest of Europe: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
Table 31. Rest of Europe: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
Table 32. Rest of Europe: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
Table 33. Recent Organic Growth Strategies in US and Europe Gene Editing Market
Table 34. Recent Inorganic Growth Strategies in the US and Europe Gene Editing Market
Table 35. Glossary of Terms, Gene Editing Market
LIST OF FIGURES
Figure 1. Gene Editing Market Segmentation
Figure 2. Gene Editing Market Segmentation, by Region
Figure 3. US and Europe Gene Editing Market Overview
Figure 4. CRISPR Segment Held Largest Share of Gene Editing Market
Figure 5. UK to Show Significant Growth During Forecast Period
Figure 6. US and Europe Gene Editing Market - Leading Country Markets (US$ Million)
Figure 7. US and Europe Gene Editing Market, Industry Landscape
Figure 8. US PEST Analysis
Figure 9. Europe PEST Analysis
Figure 10. Gene Editing Market - Key Industry Dynamics
Figure 11. Gene Editing Market Impact Analysis of Drivers and Restraints
Figure 12. US and Europe Gene Editing Market - Revenue Forecast and Analysis - 2020-2030
Figure 13. Market Positioning of Key Players in US and Europe Gene Editing Market
Figure 14. US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
Figure 15. US and Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
Figure 17. US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. US and Europe Zinc Finger Nucleases (ZFNs) Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
Figure 21. US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
Figure 25. US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
Figure 26. US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
Figure 31. US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 32. US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 33. US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
Figure 34. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 35. US Gene Editing Market- Revenue Forecast and Analysis - 2020- 2030
Figure 36. Europe Gene Editing Market- Revenue Forecast and Analysis - 2020- 2030
Figure 37. Europe: Gene Editing Market -Revenue and Forecasts to 2030, By Country (%)
Figure 38. Germany: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
Figure 39. UK: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
Figure 40. France: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
Figure 41. Italy: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
Figure 42. Spain: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
Figure 43. Rest of Europe: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
Figure 44. Growth Strategies in US and Europe Gene Editing Market
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security